Mechanism of fluconazole resistance in Candida albicans biofilms: Phase-specific role of efflux pumps and membrane sterols

Infection and Immunity

Volumn 71, Issue 8, 2003, Pages 4333-4340

  Mukherjee, Pranab K ^a   Chandra, Jyotsna ^a   Kuhn, Duncan M ^a   Ghannoum, Mahmoud A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; STEROL;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CDR GENE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG TRANSPORT; FUNGAL GENE; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS MUTANT; GENE EXPRESSION; LIPID MEMBRANE; MDR1 GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NORTHERN BLOTTING; PLANKTON; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; STRAIN DIFFERENCE; WILD TYPE;

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; BIOFILMS; CANDIDA ALBICANS; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FLUORESCENT DYES; FUNGAL PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; MEMBRANE TRANSPORT PROTEINS; MUTATION; P-GLYCOPROTEIN; RHODAMINE 123; STEROLS;

EID: 0041764578     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.8.4333-4340.2003     Document Type: Article

References (53)

1. Albertson, G. D., M. Niimi, R. D. Cannon, and H. F. Jenkinson. 1996. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40:2835-2841.
2. Anaissie, E. J., J. H. Rex, O. Uzun, and S. Vartivarian. 1998. Predictors of adverse outcome in cancer patients with candidemia. Am. J. Med. 104:238-245.
3. Anderi, J. N., M. J. Franklin, and P. S. Stewart. 2000. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 44:1818-1824.
4. Baillie, G. S., and L. J. Douglas. 1999. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol. 310:644-656.
5. Brooun, A., S. Liu, and K. Lewis. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:640-646.
6. Budtz-Jorgensen, E. 1990. Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections. Acta Odontol. Scand. 48:61-69.
7. Budtz-Jorgensen, E. 1990. Histopathology, immunology, and serology of oral yeast infections. Diagnosis of oral candidosis. Acta Odontol. Scand. 48:37-43.
8. Budtz-Jorgensen, E., and T. Lombardi. 1996. Antifungal therapy in the oral cavity. Periodontol. 2000 10:89-106.
9. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
10. Chandra, J., P. K. Mukherjee, S. D. Leidich, F. F. Faddoul, L. L. Hoyer, L. J. Douglas, and M. A. Ghannoum. 2001. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:903-908.
11. Chaudhary, P. M., and I. B. Roninson. 1991. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85-94.
12. Clark, F. S., T. Parkinson, C. A. Hitchcock, and N. A. Gow. 1996. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. Antimicrob. Agents Chemother. 40:419-425.
13. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
14. De Kievit, T. R., M. D. Parkins, R. J. Gillis, R. Srikumar, H. Ceri, K. Poole, B. H. Iglewski, and D. G. Storey. 2001. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 45:1761-1770.
15. Donlan, R. M. 2000. Role of biofilms in antimicrobial resistance. ASAIO J. 46:S47-S52.
16. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
17. Egner, R., F. E. Rosenthal, A. Kralli, D. Sanglard, and K. Kuchler. 1998. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. Mol. Biol. Cell 9:523-543.
18. Ghannoum, M. A., N. M. Moussa, P. Whittaker, I. Swairjo, and K. H. Abu-Elteen. 1992. Subinhibitory concentration of octenidine and pirtenidine: influence on the lipid and sterol contents of Candida albicans. Chemotherapy 38:46-56.
19. Ghannoum, M. A., and L. B. Rice. 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12:501-517.
20. Gygi, S. P., Y. Rochon, B. R. Franza, and R. Aebersold. 1999. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19:1720-1730.
21. Hammerle, S. P., B. Rothen-Rutishauser, S. D. Kramer, M. Gunthert, and H. Wunderli-Allenspach. 2000. P-glycoprotein in cell cultures: a combined approach to study expression, localisation, and functionality in the confocal microscope. Eur. J. Pharm. Sci. 12:69-77.
22. Hitchcock, C. A., K. J. Barrett-Bee, and N. J. Russell. 1987. The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans. J. Med. Vet. Mycol. 25:29-37.
23. Hitchcock, C. A., K. J. Barrett-Bee, and N. J. Russell. 1989. The lipid composition and permeability to the triazole antifungal antibiotic ICI 153066 of serum-grown mycelial cultures of Candida albicans. J. Gen. Microbiol. 135:1949-1955.
24. Hitchcock, C. A., N. J. Russell, and K. J. Barrett-Bee. 1987. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4. Crit. Rev. Microbiol. 15:111-115.
25. Hoyer, L. L., S. Scherer, A. R. Shatzman, and G. P. Livi. 1995. Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol. Microbiol. 15:39-54.
26. Ibrahim, A. S., and M. A. Ghannoum. 1996. Chromatographic analysis of lipids, p. 52-79. In R. Prasad (ed.), Manual on membrane lipids. Springer-Verlag, New York, N.Y.
27. Kohli, A., Smriti, K. Mukhopadhyay, A. Rattan, and R. Prasad. 2002. In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob. Agents Chemother. 46:1046-1052.
28. Kontoyiannis, D. P. 2000. Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae. J. Antimicrob. Chemother. 46:199-203.
29. Kuhn, D. M., J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70:878-888.
30. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
31. Larsen, T., and N. E. Fiehn. 1996. Resistance of Streptococcus sanguis biofilms to antimicrobial agents. APMIS 104:280-284.
32. Lyons, C. N., and T. C. White. 2000. Transcriptional analyses of antifungal drug resistance in Candida albicans. Antimicrob. Agents Chemother, 44:2296-2303.
33. Mah, T. F., and G. A. O'Toole. 2001, Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9:34-39.
34. Maira-Litran, T., D. G. Allison, and P. Gilbert. 2000. An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms. J. Antimicrob. Chemother. 45:789-795.
35. Millard, P. J., B. L. Roth, H. P. Thi, S. T. Yue, and R. P. Haugland, 1997. Development of the FUN-1 family of fluorescent probes for vacuole labeling and viability testing of yeasts. Appl. Environ. Microbiol. 63:2897-2905.
36. Mukhopadhyay, K., A. Kohli, and R. Prasad. 2002. Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob. Agents Chemother. 46:3695-3705.
37. Nguyen, M. H., J. E. Peacock, D. C. Tanner, A. J. Morris, M. L. Nguyen, D. R. Snydman, M. M. Wagener, and V. L. Yu. 1995. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch. Intern. Med. 155:2429-2435.
38. Nicastri, E., N. Petrosiillo, P. Viale, and G. Ippolito. 2001. Catheter-related bloodstream infections in HIV-infected patients. Ann. N. Y. Acad. Sci. 946:274-290.
39. O'Toole, G., H. B. Kaplan, and R. Kolter. 2000. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54:49-79.
40. O'Toole, G. A., L. A. Pratt, P. I. Watnick, D. K. Newman, V. B. Weaver, and R. Kolter, 1999. Genetic approaches to study of biofilms. Methods Enzymol. 310:91-109.
41. Prasad, R., P. De Wergifosse, A. Goffeau, and E. Balzi, 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
42. Prasad, R., S. K. Murthy, V. Gupta, and R. Prasad. 1995. Multiple drug resistance in Candida albicans. Acta Biochim. Pol. 42:497-504.
43. Ramage, G., S. Bachmann, T. F. Patterson, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49:973-980.
44. Ramage, G., W. K. Vande, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
45. Ramage, G., B. L. Wickes, and J. L. Lopez-Ribot. 2001. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am. Clin. Lab 20:42-44.
46. Rogers, P. D., and K. S. Barker. 2002, Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis. Antimicrob. Agents Chemother. 46:3412-3417.
47. Sanati, H., P. Belanger, R. Fratti, and M. Ghannoum. 1997. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob. Agents Chemother. 41:2492-2496.
48. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40:2300-2305.
49. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
50. Stewart, P. S. 2002. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. 292:107-113.
51. Stewart, P. S., and J. W. Costerton. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
52. Vandenheuvel, F. A., and A. S. Court. 1968. Reference high-efficiency nonpolar packed columns for the gas-liquid chromatography of nanogram amounts of steroids. I. Retention time data. J. Chromatogr. 38:439-459.
53. White, T. C. 1997. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.